Florencia Halperin, MD, Chief Medical Officer at Form™
Recent research has changed the narrative about obesity, debunking the myth that it is a lifestyle choice and recognizing it as a medical condition. With a better understanding of the role of the brain in weight regulation, more effective medications are available, some of which are taken by women facing fertility issues. Join Dr. Carrie Bedient from The Fertility Center of Las Vegas, Dr. Abby Eblen from Nashville Fertility Center and Dr. Susan Hudson from Texas Fertility Center for an informative discussion with Dr. Florencia Halperin, a board certified endocrinologist specializing in weight loss as chief medical officer at Form Health. Dr. Halperin explains the latest advances in anti-obesity medication, cost considerations in new vs. older drugs and the multi-faceted approach to weight loss including diet and exercise. For those taking anti-obesity medication who are considering fertility treatment, Dr. Halperin explains the importance of developing a transition plan to safely support the pathway to pregnancy.
Today’s episode is brought to you by Theralogix, Progyny, and Cicero Diagnostics